MedixMAB™ Antibodies & MedixAntigens™

Most recent

28 Mar

CACLP 2021

Booth N2-T002

Chongqing, China

New tumor products

December 22, 2020

New Serum Amyloid A monoclonal antibodies

December 1, 2020

Product Specifications to new branding

November 16, 2020

Change in purity method of recombinant MedixAntigens™

November 16, 2020

Delivering in vitro diagnostics expertise for over 100 years

November 3, 2020

Widening MedixMAB™ Cardiac marker portfolio: GDF-15

October 29, 2020

D-dimer, IL-6, and other Bioreagents for IVD tests

October 27, 2020

Wide range of excellent diagnostic raw materials for flu season

October 13, 2020

Combined portfolio for Covid-19 assay development

September 29, 2020

IVD market trends in Covid-19 pandemic

September 28, 2020

We now offer more with combined product portfolios

September 14, 2020